Pamela G. Marrone, Director at 180 Life Sciences Corp. (ATNF), bought 7,082 shares at $1.06 ($8K) on 2023-05-18, disclosed to the SEC on 2023-05-19.
Open-market purchase of $8k ATNF by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| MBII | SELL | 2022-03-28 | $25K | — | Filing → |
| ATNF | BUY | 2021-12-10 | $4K | — | Filing → |
| MBII | SELL | 2021-08-25 | $25K | — | Filing → |